Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04551521
Title CRAFT: The NCT-PMO-1602 Phase II Trial
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors German Cancer Research Center
Indications

Advanced Solid Tumor

Therapies

Atezolizumab

Atezolizumab + Ipatasertib

Atezolizumab + Pertuzumab + Trastuzumab

Atezolizumab + Cobimetinib

Alectinib

Atezolizumab + Cobimetinib + Vemurafenib

Age Groups: adult | senior
Covered Countries DEU

Additional content available in CKB BOOST